Paraneoplastic cerebellar degeneration associated with an onconeural antibody against creatine kinase, brain-type

Syuichi Tetsuka1, Kaoru Tominaga, Eriko Ohta

  • 1Division of Neurology, Department of Internal Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498 Japan; Department of Biochemistry, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498 Japan.

Insights

Researchers identified a new onconeural antibody, anti-creatine kinase, brain-type (CKB), in a patient with paraneoplastic cerebellar degeneration (PCD) and bladder cancer. This discovery may aid in diagnosing PCD, a rare neurological complication of cancer.

Area of Science:

  • Neuroimmunology
  • Oncology
  • Proteomics

Background:

  • Paraneoplastic neurological syndromes (PNS), like paraneoplastic cerebellar degeneration (PCD), arise from onconeural immunity, where anti-cancer immune responses mistakenly target neural tissues.
  • Standard diagnostic markers for PNS, including specific onconeural antibodies, were absent in a patient with PCD and urothelial carcinoma (UC).

Observation:

  • A proteomic approach using mass spectrometry was employed to identify novel autoantibodies in the patient's serum and cerebrospinal fluid.
  • The study focused on identifying an antibody that cross-reacts with both cerebellar neurons and the patient's UC tissues.

Findings:

  • A novel autoantibody, anti-creatine kinase, brain-type (CKB), was identified in the patient's serum and cerebrospinal fluid.
  • Immunohistochemistry confirmed that anti-CKB antibody targets both cerebellar neurons and UC tissues.
  • Anti-CKB antibody was detected in three additional PCD patients but not in healthy donors or bladder cancer patients without PCD, suggesting its specificity for PCD.

Implications:

  • Anti-CKB antibody represents a new potential biomarker for diagnosing paraneoplastic cerebellar degeneration.
  • The findings expand the repertoire of known onconeural antibodies associated with PNS, improving diagnostic capabilities.
  • This research highlights the importance of exploring novel autoantibodies in challenging PNS cases, particularly those lacking established serological markers.

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...